Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143079671> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2143079671 endingPage "19" @default.
- W2143079671 startingPage "19" @default.
- W2143079671 abstract "Several large placebo-controlled trials have confirmed that angiotensin converting enzyme (ACE) inhibitors significantly reduce mortality aid morbidity in all functional grades of congestive heart failure (CHF), nevertheless only a proportion of patients who may benefit from treatment are priscribed an ACE inhibitor. One of the perceived difficulties is the occurrence of first-dose hypotension in susceptible patients. A double-blind, randomised, single-dose therapy, parallel-group study was conducted with the aim to compare the first-dose responses to low dose ACE inhibitors captopril and perindopril in patients with stable chronic heart failure. Seventy patients (New York Heart Association class I-IV) were included. Blood pressure was recorded every 15 minutes 2 hours before starting treatment. The mean of these readings was taken as the baseline blood pressure. Patients were randomised to receive a single-dose of captopril 6.25 mg or perindopril 2 mg. After taking the drug, blood pressure was monitored every 15 minutes for 2 hours, every 30 minutes during 5 hours then hourly after 2 hours. The maximum mean arterial pressure fall from baseline of perindopril was 0.85 mmHg compared to captopril 4.60 mmHg. The maximum mean systolic fall from baseline of perindopril was 3 '31 'mmHg compared to captopril 6.76 mmHg while the maximum mean diastolic fall from baseline of perindopril was 1.08 mmHg compared to captopril 2.63 mmHg. The hypotensive effect of the captopril group started soon after dosing and reached its maximum after 1 to 2 hours while perindopril showed slight reduction of systolic after 1 hour and slight reduction of diastolic after 4 hours. Compared to captopril, perindopril seemed to be less likely to cause first-dose hypotension in patients with heart failure. (Med J Indones 2002; 11: 19-23)Keywords: first dose hypotension, perindopril, captopril, chronic heart failure" @default.
- W2143079671 created "2016-06-24" @default.
- W2143079671 creator A5026681458 @default.
- W2143079671 creator A5030653990 @default.
- W2143079671 creator A5037481883 @default.
- W2143079671 creator A5061257251 @default.
- W2143079671 creator A5082383586 @default.
- W2143079671 creator A5086060242 @default.
- W2143079671 creator A5090339889 @default.
- W2143079671 creator A5058138703 @default.
- W2143079671 date "2002-02-01" @default.
- W2143079671 modified "2023-09-27" @default.
- W2143079671 title "A randomized comparative trial of first-dose response to Angiotensin- Converting Enzyme Perindopril and Captopril in Indonesian heart failure patients" @default.
- W2143079671 cites W1608446089 @default.
- W2143079671 cites W2050771711 @default.
- W2143079671 cites W2413957779 @default.
- W2143079671 doi "https://doi.org/10.13181/mji.v11i1.45" @default.
- W2143079671 hasPublicationYear "2002" @default.
- W2143079671 type Work @default.
- W2143079671 sameAs 2143079671 @default.
- W2143079671 citedByCount "0" @default.
- W2143079671 crossrefType "journal-article" @default.
- W2143079671 hasAuthorship W2143079671A5026681458 @default.
- W2143079671 hasAuthorship W2143079671A5030653990 @default.
- W2143079671 hasAuthorship W2143079671A5037481883 @default.
- W2143079671 hasAuthorship W2143079671A5058138703 @default.
- W2143079671 hasAuthorship W2143079671A5061257251 @default.
- W2143079671 hasAuthorship W2143079671A5082383586 @default.
- W2143079671 hasAuthorship W2143079671A5086060242 @default.
- W2143079671 hasAuthorship W2143079671A5090339889 @default.
- W2143079671 hasBestOaLocation W21430796711 @default.
- W2143079671 hasConcept C126322002 @default.
- W2143079671 hasConcept C142724271 @default.
- W2143079671 hasConcept C164705383 @default.
- W2143079671 hasConcept C204787440 @default.
- W2143079671 hasConcept C27016395 @default.
- W2143079671 hasConcept C27081682 @default.
- W2143079671 hasConcept C2778198053 @default.
- W2143079671 hasConcept C2779200603 @default.
- W2143079671 hasConcept C2779479957 @default.
- W2143079671 hasConcept C2779611605 @default.
- W2143079671 hasConcept C42219234 @default.
- W2143079671 hasConcept C71924100 @default.
- W2143079671 hasConcept C84393581 @default.
- W2143079671 hasConceptScore W2143079671C126322002 @default.
- W2143079671 hasConceptScore W2143079671C142724271 @default.
- W2143079671 hasConceptScore W2143079671C164705383 @default.
- W2143079671 hasConceptScore W2143079671C204787440 @default.
- W2143079671 hasConceptScore W2143079671C27016395 @default.
- W2143079671 hasConceptScore W2143079671C27081682 @default.
- W2143079671 hasConceptScore W2143079671C2778198053 @default.
- W2143079671 hasConceptScore W2143079671C2779200603 @default.
- W2143079671 hasConceptScore W2143079671C2779479957 @default.
- W2143079671 hasConceptScore W2143079671C2779611605 @default.
- W2143079671 hasConceptScore W2143079671C42219234 @default.
- W2143079671 hasConceptScore W2143079671C71924100 @default.
- W2143079671 hasConceptScore W2143079671C84393581 @default.
- W2143079671 hasLocation W21430796711 @default.
- W2143079671 hasLocation W21430796712 @default.
- W2143079671 hasOpenAccess W2143079671 @default.
- W2143079671 hasPrimaryLocation W21430796711 @default.
- W2143079671 hasRelatedWork W2051080813 @default.
- W2143079671 hasRelatedWork W2053303672 @default.
- W2143079671 hasRelatedWork W2073783064 @default.
- W2143079671 hasRelatedWork W2143079671 @default.
- W2143079671 hasRelatedWork W22745184 @default.
- W2143079671 hasRelatedWork W2412871786 @default.
- W2143079671 hasRelatedWork W2413957779 @default.
- W2143079671 hasRelatedWork W2522552519 @default.
- W2143079671 hasRelatedWork W2917416677 @default.
- W2143079671 hasRelatedWork W4252783139 @default.
- W2143079671 isParatext "false" @default.
- W2143079671 isRetracted "false" @default.
- W2143079671 magId "2143079671" @default.
- W2143079671 workType "article" @default.